Inventor · disambiguated record
Deepak Phadke
Also filed as: PHADKE DEEPAK · PHADKE DEEPAK S
26 granted patents·17 pending applications·301 citations·filing 1992–2025
96Inventor score
Files withVANDA PHARMACEUTICALS INC27HOECHST MARION ROUSSEL INC3MERRELL DOW PHARMA3AVENTIS PHARMA INC2BIRZNIEKS GUNTHER2
Top patents by PatentIndex Score
43 records- 0197US10829465B2Highly purified pharmaceutical grade tasimelteonVANDA PHARMACEUTICALS INC·Filed 2020·Granted Nov 10, 2020·10 cites·20 claims
- 0296US12447141B2Liquid tasimelteon formulations and methods of use thereofVANDA PHARMACEUTICALS INC·Filed 2024·Granted Oct 21, 2025·1 cites·25 claims
- 0395US11759446B2Liquid tasimelteon formulations and methods of use thereofVANDA PHARMACEUTICALS INC·Filed 2021·Granted Sep 19, 2023·2 cites·14 claims
- 0495US10611744B2Highly purified pharmaceutical grade tasimelteonVANDA PHARMACEUTICALS INC·Filed 2018·Granted Apr 7, 2020·10 cites·9 claims
- 0594US10071977B2Highly purifid pharmaceutical grade tasimelteonVANDA PHARMACEUTICALS INC·Filed 2015·Granted Sep 11, 2018·14 cites·24 claims
- 0693US11760740B2Highly purified pharmaceutical grade tasimelteonVANDA PHARMACEUTICALS INC·Filed 2023·Granted Sep 19, 2023·1 cites·40 claims
- 0791US11566011B2Highly purified pharmaceutical grade tasimelteonVANDA PHARMACEUTICALS INC·Filed 2021·Granted Jan 31, 2023·1 cites·5 claims
- 0887US12440470B2Liquid tasimelteon formulations and methods of use thereofVANDA PHARMACEUTICALS INC·Filed 2023·Granted Oct 14, 2025·0 cites·3 claims
- 0987US2024325339A1Melatonin agonist treatmentVANDA PHARMACEUTICALS INC·Filed 2024·Application pending·0 cites
- 1086US12049457B2Highly purified pharmaceutical grade tasimelteonVANDA PHARMACEUTICALS INC·Filed 2023·Granted Jul 30, 2024·0 cites·28 claims
- 1186US11203581B2Highly purified pharmaceutical grade tasimelteonVANDA PHARMACEUTICALS INC·Filed 2020·Granted Dec 21, 2021·1 cites·12 claims
- 1286US5738872APharmaceutical composition for piperidinoalkanol compoundsHOECHST MARION ROUSSEL INC·Filed 1996·Granted Apr 14, 1998·49 cites·18 claims
- 1385US9212129B2Metabolites of (1R-trans)-N-[[2-(2,3-dihydro-4-benzofuranyl)cyclopropyl]methyl]propanamideVANDA PHARMACEUTICALS INC·Filed 2013·Granted Dec 15, 2015·5 cites·12 claims
- 1484US10874659B2Iloperidone metabolite for use in the treatment of psychiatric disordersVANDA PHARMACEUTICALS INC·Filed 2013·Granted Dec 29, 2020·6 cites·7 claims
- 1584US6113942APharmaceutical composition for piperidinoalkanol compoundsAVENTIS PHARMA INC·Filed 1998·Granted Sep 5, 2000·36 cites·5 claims
- 1684US5855912APharmaceutical compositions for piperidinalkanol compoundsHOECHST MARION ROUSSEL INC·Filed 1997·Granted Jan 5, 1999·39 cites·25 claims
- 1781US8129408B2Pharmaceutical composition for piperidinoalkanol compoundsORTYL THOMAS T·Filed 2009·Granted Mar 6, 2012·5 cites·5 claims
- 1881US5932247APharmaceutical composition for piperidinoalkanol compoundsHOECHST MARION ROUSSEL INC·Filed 1997·Granted Aug 3, 1999·32 cites·4 claims
- 1981US2023021493A1Melatonin agonist treatmentVANDA PHARMACEUTICALS INC·Filed 2022·Application pending·0 cites
- 2078US2024016791A1Iloperidone metabolite for use in the treatment of psychiatric disordersVANDA PHARMACEUTICALS INC·Filed 2023·Application pending·0 cites
- 2177US5302396ASuperior tasting composition having porous particles and the process of preparing such pharmaceutical compositionMERRELL DOW PHARMA·Filed 1992·Granted Apr 12, 1994·55 cites·2 claims
- 2276US2025320188A1Highly purified pharmaceutical grade tasimelteonVANDA PHARMACEUTICALS INC·Filed 2025·Application pending·0 cites
- 2375US11202770B2Liquid tasimelteon formulations and methods of use thereofVANDA PHARMACEUTICALS INC·Filed 2020·Granted Dec 21, 2021·0 cites·14 claims
- 2474US9617203B2Metabolites of (1R-trans)-N-[[2-(2,3-dihydro-4-benzofuranyl)cyclopropyl]methyl]propanamideVANDA PHARMACEUTICALS INC·Filed 2015·Granted Apr 11, 2017·1 cites·12 claims
- 2572US2020397741A1Melatonin agonist treatmentVANDA PHARMACEUTICALS INC·Filed 2020·Application pending·0 cites
- 2670US12304896B2Highly purified pharmaceutical grade tasimelteonVANDA PHARMACEUTICALS INC·Filed 2024·Granted May 20, 2025·0 cites·17 claims
- 2767US5437873ASuperior tasting pharmaceutical composition having porous particles and the process of preparing such pharmaceutical compositionMERRELL DOW PHARMA·Filed 1994·Granted Aug 1, 1995·21 cites·15 claims
- 2865US2021015809A1Iloperidone metabolite for use in the treatment of psychiatric disordersVANDA PHARMACEUTICALS INC·Filed 2020·Application pending·0 cites
- 2964US10233142B2Metabolites of (1R-trans)-N-[[2-(2,3-dihydro-4-benzofuranyl)cyclopropyl]methyl]propanamideVANDA PHARMACEUTICALS INC·Filed 2017·Granted Mar 19, 2019·0 cites·6 claims
- 3064US2015080464A1Melatonin agonist treatmentVANDA PHARMACEUTICALS INC·Filed 2014·Application pending·0 cites
- 3164US2018243258A1Melatonin agonist treatmentVANDA PHARMACEUTICALS INC·Filed 2018·Application pending·0 cites
- 3263US9850199B2Metabolites of (1R-trans)-N-[[2-(2,3-dihydro-4-benzofuranyl)cyclopropyl]methyl]propanamideVANDA PHARMACEUTICALS INC·Filed 2017·Granted Dec 26, 2017·0 cites·2 claims
- 3363US2007249671A1Pharmaceutical composition for piperidinoalkanol compoundsAVENTIS PHARMA INC·Filed 2007·Application pending·0 cites
- 3461US2009105333A1Melatonin agonist treatmentBIRZNIEKS GUNTHER·Filed 2007·Application pending·0 cites
- 3559US2016354337A1Melatonin agonist treatmentVANDA PHARMACEUTICALS INC·Filed 2016·Application pending·0 cites
- 3655US2023026577A1Ophthalmic Pharmaceutical CompositionsVANDA PHARMACEUTICALS INC·Filed 2020·Application pending·0 cites
- 3754US2003203020A1Pharmaceutical compositions for piperidinoalkanol compoundsFiled 2003·Application pending·0 cites
- 3852US8865210B2Stable dosage formulations of imidazolylalkyl-pyridinesLAVEDAN CHRISTIAN N·Filed 2007·Granted Oct 21, 2014·0 cites·12 claims
- 3951US5266334ASugar-free dry mix cellulose ether compositions as bulk laxativesMERRELL DOW PHARMA·Filed 1992·Granted Nov 30, 1993·12 cites·4 claims
- 4051US2002106405A1Pharmaceutical composition for piperidinoalkanol compoundsFiled 2002·Application pending·0 cites
- 4150US2001022973A1Pharmaceutical composition for piperidinoalkanol compoundsFiled 2001·Application pending·0 cites
- 4244US2009209638A1Treatment for depressive disordersBIRZNIEKS GUNTHER·Filed 2007·Application pending·0 cites
- 4340US2012136050A1Use of a melatonin agonist for the treatment of sleep disorders including primary insomniaPOLYMEROPOULOS MIHAEL H·Filed 2010·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Deepak Phadke files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →